These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35609344)

  • 1. Pyronaridine Protects against SARS-CoV-2 Infection in Mouse.
    Puhl AC; Gomes GF; Damasceno S; Godoy AS; Noske GD; Nakamura AM; Gawriljuk VO; Fernandes RS; Monakhova N; Riabova O; Lane TR; Makarov V; Veras FP; Batah SS; Fabro AT; Oliva G; Cunha FQ; Alves-Filho JC; Cunha TM; Ekins S
    ACS Infect Dis; 2022 Jun; 8(6):1147-1160. PubMed ID: 35609344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses.
    Ardanuy J; Johnson R; Dillen C; Taylor L; Hammond H; Weston S; Frieman M
    mBio; 2023 Oct; 14(5):e0158723. PubMed ID: 37581442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine:
    Puhl AC; Fritch EJ; Lane TR; Tse LV; Yount BL; Sacramento CQ; Fintelman-Rodrigues N; Tavella TA; Maranhão Costa FT; Weston S; Logue J; Frieman M; Premkumar L; Pearce KH; Hurst BL; Andrade CH; Levi JA; Johnson NJ; Kisthardt SC; Scholle F; Souza TML; Moorman NJ; Baric RS; Madrid PB; Ekins S
    ACS Omega; 2021 Mar; 6(11):7454-7468. PubMed ID: 33778258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
    Lane TR; Massey C; Comer JE; Freiberg AN; Zhou H; Dyall J; Holbrook MR; Anantpadma M; Davey RA; Madrid PB; Ekins S
    Antiviral Res; 2020 Sep; 181():104863. PubMed ID: 32682926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms.
    Puhl AC; Fritch EJ; Lane TR; Tse LV; Yount BL; Sacramento CQ; Tavella TA; Costa FTM; Weston S; Logue J; Frieman M; Premkumar L; Pearce KH; Hurst BL; Andrade CH; Levi JA; Johnson NJ; Kisthardt SC; Scholle F; Souza TML; Moorman NJ; Baric RS; Madrid P; Ekins S
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2
    Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective.
    Seifert M; Bera SC; van Nies P; Kirchdoerfer RN; Shannon A; Le TT; Meng X; Xia H; Wood JM; Harris LD; Papini FS; Arnold JJ; Almo S; Grove TL; Shi PY; Xiang Y; Canard B; Depken M; Cameron CE; Dulin D
    Elife; 2021 Oct; 10():. PubMed ID: 34617885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remdesivir for COVID-19].
    Fujita Y
    Nihon Yakurigaku Zasshi; 2022; 157(1):31-37. PubMed ID: 34980809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.
    Ordonez AA; Bullen CK; Villabona-Rueda AF; Thompson EA; Turner ML; Merino VF; Yan Y; Kim J; Davis SL; Komm O; Powell JD; D'Alessio FR; Yolken RH; Jain SK; Jones-Brando L
    Commun Biol; 2022 Mar; 5(1):242. PubMed ID: 35304580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
    Nili A; Farbod A; Neishabouri A; Mozafarihashjin M; Tavakolpour S; Mahmoudi H
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 33210457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    Abdelnabi R; Foo CS; Kaptein SJF; Boudewijns R; Vangeel L; De Jonghe S; Jochmans D; Weynand B; Neyts J
    J Virol; 2022 Aug; 96(16):e0075822. PubMed ID: 35924921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
    Bafna K; White K; Harish B; Rosales R; Ramelot TA; Acton TB; Moreno E; Kehrer T; Miorin L; Royer CA; García-Sastre A; Krug RM; Montelione GT
    Cell Rep; 2021 May; 35(7):109133. PubMed ID: 33984267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
    Dampalla CS; Zheng J; Perera KD; Wong LR; Meyerholz DK; Nguyen HN; Kashipathy MM; Battaile KP; Lovell S; Kim Y; Perlman S; Groutas WC; Chang KO
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34210738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Inhibitors of Main Protease (M
    Mondal S; Chen Y; Lockbaum GJ; Sen S; Chaudhuri S; Reyes AC; Lee JM; Kaur AN; Sultana N; Cameron MD; Shaffer SA; Schiffer CA; Fitzgerald KA; Thompson PR
    J Am Chem Soc; 2022 Nov; 144(46):21035-21045. PubMed ID: 36356199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.